Pharmaceutical companies behind weight loss and diabetes medication such as Ozempic are facing a lawsuit that could potentially pay out more than $2 billion. Rating: Mostly True (About this rating?) ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

The word "Ozempic" has become popular thanks to the catchy commercial jingle O-O-O-Ozempic! Ozempic was once an injectable weight loss drug that celebrities were initially taking under the radar.

Ozempic’s website says its GLP-1 has more FDA-approved uses than other GLP-1s. Justin Long and John Hodgman star in comedic Ozempic ads to educate about diabetes. The campaign encourages informed ...

The cost of GLP-1 medications varies widely, ranging from around $199 to over $1,500. Insurance coverage for GLP-1s is more ...

A new study reported that Novo Nordisk spent $7.5 million over 2 years on more than 15,000 internet keywords — many focused on weight loss — that drove 2.4 million paid visits to its Ozempic.com ...

Counterfeit Ozempic pens, which appear to be relabelled insulin pens, have been detected in Australia and have caused a ...

Pharmaceutical companies behind weight loss and diabetes medication such as Ozempic are facing a lawsuit that could potentially pay out more than $2 billion. There is multidistrict litigation, or an ...